Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating thyroiditis, and preparation method and application thereof

A technology of thyroiditis and composition, which is applied in the field of pharmaceutical composition for the treatment of thyroiditis, and can solve the problems of large side effects and many adverse reactions

Inactive Publication Date: 2020-12-08
MUDANJIANG MEDICAL UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned treatment methods have relatively large side effects and many adverse reactions, and the development of safe and effective drugs for the treatment of thyroiditis has become a problem to be solved urgently in the prior art.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating thyroiditis, and preparation method and application thereof
  • Pharmaceutical composition for treating thyroiditis, and preparation method and application thereof
  • Pharmaceutical composition for treating thyroiditis, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] A pharmaceutical composition for treating thyroiditis, comprising pulverizing and mixing 0.2 g of compound of formula I, 0.07 g of kaempferol, 0.05 g of β-sitosterol and 0.5 g of acteosin glucoside.

Embodiment 2

[0024] A pharmaceutical composition for treating thyroiditis, comprising pulverizing and mixing 0.3 g of compound of formula I, 0.06 g of kaempferol, 0.06 g of β-sitosterol and 0.4 g of acteosin glucoside.

Embodiment 3

[0026] A pharmaceutical composition for treating thyroiditis, comprising pulverizing and mixing 0.07 g of kaempferol, 0.05 g of β-sitosterol and 0.7 g of calycosin glucoside.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating thyroiditis. The pharmaceutical composition for treating thyroiditis comprises the following components in parts by weight: 0.2-0.4 part of a compound shown as a formula I, 0.06-0.08 part of kaempferol, 0.03-0.08 part of beta-sitosterol and 0.4-0.8 part of calycosin-7-glucoside; and the pharmaceutical composition is externally used.Experiments show that the various components of the pharmaceutical composition with the compound shown in the formula I, kaempferol, beta-sitosterol and calycosin-7-glucoside as main components havea synergistic effect; various indexes of serum can be improved; and the pharmaceutical composition has a treatment effect on thyroiditis.

Description

technical field [0001] The invention belongs to the field of pharmaceutical composition preparations, in particular to a pharmaceutical composition for treating thyroiditis. Background technique [0002] Thyroiditis is a heterogeneous disease involving the thyroid gland caused by various reasons, and women aged 30-50 are the high-risk group. The etiology of thyroiditis is complex and diverse. For example, excessive iodine intake or iodine deficiency can change the structure and function of the thyroid gland, and a high-iodine diet can also easily induce malignant transformation of the thyroid gland; the massive secretion of thyroid-stimulating hormone caused by radiation damage can also promote the development of thyroid cells. Malignant transformation; genetic factors such as chromosomal genetic factors may also promote malignant transformation of thyroid cells; the cause of the disease is closely related to living habits, eating habits and emotional factors. [0003] Due ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/519A61K31/352A61K31/575A61K31/7048A61P5/14A61P29/00
CPCA61K31/352A61K31/519A61K31/575A61K31/7048A61P5/14A61P29/00A61K2300/00
Inventor 史春静秦佳其孙海峰佟艳杨文萍吕士红马晓霞
Owner MUDANJIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com